Celebrating the 99th Birth Anniversary of Indravadan Modi: A Tribute to a Visionary Leader and Cadila Pharmaceuticals Employees’ Pledge to Donate Blood
Ahmedabad, February 18, 2025: On the 99th birth anniversary of the late Indravadan Modi, the visionary founder of Cadila Pharmaceuticals, the company came together to honour his extraordinary legacy. Indravadan Modi, a pioneer in the pharmaceutical industry, built Cadila Pharmaceuticals with a steadfast commitment to accessible, affordable healthcare, influencing millions of lives worldwide. His legacy continues to inspire, shaping the values and mission of the company today.
In a heartfelt tribute to Indravadan Modi’s enduring vision, Cadila Pharmaceuticals organized a significant blood donation initiative. Employees across the organization pledged their commitment to the cause, with a large number volunteering to donate blood. This powerful display of solidarity was not just a ceremonial act but also a pledge by the employees to contribute selflessly to the well-being of others, reflecting the values of compassion, service, and humanity that Indravadan Modi championed throughout his life.
The blood donation drive was a collective commitment, with employees from various facilities making the decision to donate, in honour of the company’s founder. The act of donating blood is symbolic of the company’s broader mission—serving humanity through impactful actions that go beyond business objectives, in keeping with Indravadan Modi's vision of making a positive difference in society.
Through this initiative, Cadila Pharmaceuticals continues to honour its founder’s legacy by encouraging a culture of giving, compassion, and social responsibility. The company's dedication to improving health outcomes extends beyond the laboratory and production lines, actively shaping the communities it serves.
About Cadila Pharmaceuticals Limited
Cadila Pharmaceuticals Ltd. is one of India's leading integrated privately held pharmaceutical firms, located in Ahmedabad, Gujarat.
The firm develops and produces pharmaceutical products in India and sells and distributes them in over 100 countries. The organization places a high emphasis and priority on research, whether it is in biotechnology, APIs, formulations, plant tissue culture, or phytochemistry to innovate in various therapeutic areas including gastrointestinal, cardiology, pulmonary, oncology, gynaecology, cardiovascular, diabetology, and osteology.
Its undaunted commitment to create affordable miracles in therapeutic areas with significant unmet medical needs to serve society and the community at large has led to several world-first breakthroughs.
Issued By:
Jatin Aggarwal
President – Cadila Pharmaceuticals Limited
Email: Jatin.aggarwal@cadilapharma.com